Related Experiment Videos
Gene amplifications in advanced-stage human prostate cancer
1Service d'Urologie, Hôpital Morvan, Brest, France.
Urological Research
|January 1, 1995
Summary
Proto-oncogene amplification in prostate cancer is rare. While c-myc and c-erbB2 amplifications were absent, int-2 amplification occurred in one advanced prostate tumor, suggesting a potential role in prostate carcinogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gene amplification is a key mechanism of proto-oncogene alteration in human tumors.
- Specific proto-oncogene amplifications (N-myc, c-erbB2, int-2) have prognostic value in various cancers.
- Prostate adenocarcinoma, a hormone-dependent cancer, has not been extensively studied for these specific proto-oncogene amplifications.
Purpose of the Study:
- To investigate the presence of c-myc, c-erbB2, and int-2 proto-oncogene amplifications in human prostate adenocarcinoma.
- To determine if these amplifications correlate with tumor stage or metastatic potential.
Main Methods:
- Southern blotting technique was employed.
- Analysis was performed on 15 human prostate adenocarcinoma specimens, including advanced stages (C, D1, D2).
Main Results:
- Amplification of c-myc and c-erbB2 proto-oncogenes was not detected in any of the prostate cancer specimens.
- Int-2 proto-oncogene amplification was identified in one advanced-stage tumor (Stage D) that had metastasized to bone.
- Six Stage D tumors were analyzed, with int-2 amplification found in one.
Conclusions:
- The study confirms the absence of c-myc and c-erbB2 amplification in prostate adenocarcinoma, contrasting with findings in breast cancer.
- Int-2 amplification is a rare event in advanced prostate cancer but was observed in a case with bone metastasis.
- Further research is needed to establish the exact frequency and functional significance of int-2 amplification in prostate carcinogenesis.